Source - RNS
RNS Number : 6800M
PJSC Pharmstandard
17 October 2016
 

Moscow, October 17, 2016

PJSC Pharmstandard (LSE: PHST IL, МОЕХ: PHST RU) (hereinafter the "Company" or "Pharmstandard") announces the receipt of the request for buy-out of Pharmstandard's shares (the "Request").

On October 14, 2016 the Company received from Augment Investments Limited, its controlling shareholder, the request for buy-out of Pharmstandard's shares. The Request states that Augment Investments Limited and its affiliates own 98.12% of the shareholders capital.

The buy-out is executed under Russian law and the proposed buy-out price has been set out in accordance with the requirements of Article 84.8(4) of the Federal Law "On Joint Stock Companies".

The proposed buy-out price equals to RUB 1,050 per one Share and exceeds Market value of one Share by RUB 10. The Market value of one Share has been determined by an independent appraiser (Share Appraisal Report No. 015/16 dated 31 August 2016) and equaled to RUB 1,040 per one Share.

The record date (the date on which the list of owners of the Shares to be bought is determined) is November 29, 2016 (the 46th day following the date the Request is sent to PJSC Pharmstandard).

Owners of the Shares to be bought out are authorized to provide the Registrar of PJSC Pharmstandard with an application with its bank account details at: 107996, Moscow, Stromynka Str., h. 18, bl. 13, for JSC R.O.S.T. Registrar.

_____________________________________________________________________________________

***

FORWARD-LOOKING STATEMENTS

THIS RELEASE MAY INCLUDE STATEMENTS THAT ARE, OR MAY BE DEEMED TO BE, "FORWARD-LOOKING STATEMENTS". THESE FORWARD-LOOKING STATEMENTS SPEAK ONLY AS AT THE DATE OF THIS RELEASE. THESE FORWARD-LOOKING STATEMENTS CAN BE IDENTIFIED BY THE USE OF FORWARD-LOOKING TERMINOLOGY, INCLUDING THE WORDS "TARGETS", "BELIEVES", "EXPECTS", "AIMS", "INTENDS", "WILL", "MAY", "ANTICIPATES", "WOULD", "COULD" OR "SHOULD" OR SIMILAR EXPRESSIONS OR, IN EACH CASE THEIR NEGATIVE OR OTHER VARIATIONS OR BY DISCUSSION OF STRATEGIES, PLANS, OBJECTIVES, GOALS, FUTURE EVENTS OR INTENTIONS. THESE FORWARD-LOOKING STATEMENTS ALL INCLUDE MATTERS THAT ARE NOT HISTORICAL FACTS. BY THEIR NATURE, SUCH FORWARD-LOOKING STATEMENTS INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER IMPORTANT FACTORS BEYOND THE COMPANY'S CONTROL THAT COULD CAUSE THE ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS OF THE COMPANY TO BE MATERIALLY DIFFERENT FROM FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH FORWARD-LOOKING STATEMENTS. SUCH FORWARD-LOOKING STATEMENTS ARE BASED ON NUMEROUS ASSUMPTIONS REGARDING THE COMPANY'S PRESENT AND FUTURE BUSINESS STRATEGIES AND THE ENVIRONMENT IN WHICH THE COMPANY WILL OPERATE IN THE FUTURE. FORWARD-LOOKING STATEMENTS ARE NOT GUARANTEES OF FUTURE PERFORMANCE. THERE ARE MANY FACTORS THAT COULD CAUSE THE COMPANY'S ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS TO DIFFER MATERIALLY FROM THOSE EXPRESSED IN SUCH FORWARD-LOOKING STATEMENTS. THE COMPANY EXPRESSLY DISCLAIMS ANY OBLIGATION OR UNDERTAKING TO DISSEMINATE ANY UPDATES OR REVISIONS TO ANY FORWARD-LOOKING STATEMENTS CONTAINED HEREIN TO REFLECT ANY CHANGE IN THE COMPANY'S EXPECTATIONS WITH REGARD THERETO OR ANY CHANGE IN EVENTS, CONDITIONS OR CIRCUMSTANCES ON WHICH ANY SUCH STATEMENTS ARE BASED.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGGUAUUPQUMM